VEGFA and neoplasm: Second, according the Jain hypothesis, treatment with anti-angiogenic agents such as bevicuzamb, which captures free human vascular endothelial growth factor-A (VEGF-A, are assumed to improve chemotherapy efficacy by transiently normalizing the leaky character of the tumor vessels, leading to more effective oxygen and drug delivery [42].